Related Experiment Video
Updated: May 5, 2026
05:20
Separation of Plasmodium falciparum Late Stage-infected Erythrocytes by Magnetic Means
Published on: March 2, 2013
13.8K
Post-Artesunate Delayed Hemolysis: Anything That Can Go Wrong Will Go Wrong-Murphy's Law
Beliza Chemutai1, Muhammed Omar Ali1, Jaimin Vinod Varsani2
1Department of Internal Medicine Gulu Regional Referral Hospital Gulu Uganda.
Clinical Case Reports
|December 30, 2024
Summary
Post-malarial anemia after intravenous artesunate treatment may indicate delayed hemolysis. Close monitoring is crucial for patients treated for severe malaria, irrespective of their history or location.
Area of Science:
- Infectious Diseases
- Hematology
- Pharmacology
Background:
- Severe malaria is a life-threatening condition often treated with intravenous artesunate.
- Post-malarial anemia is a known complication following malaria treatment.
- Delayed hemolysis is a rare but serious adverse effect of certain antimalarial drugs.
Purpose of the Study:
- To highlight the importance of considering post-artesunate delayed hemolysis in patients with post-malarial anemia.
- To emphasize the need for vigilant monitoring of patients treated with intravenous artesunate for severe malaria.
Main Methods:
- This is a clinical observation and differential diagnosis discussion.
- Review of patient cases and relevant literature on artesunate treatment and hemolysis.
Main Results:
- Post-malarial anemia can be a presenting sign of delayed hemolysis after intravenous artesunate.
- This complication can occur even in patients with no prior malaria exposure or in non-endemic areas.
Conclusions:
- Post-artesunate delayed hemolysis is a critical differential diagnosis in patients with post-malarial anemia.
- Continuous monitoring for delayed hemolysis is essential for all patients treated with intravenous artesunate for severe malaria.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:16Drug toxicity: Idiosyncratic Reactions
220
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
220
01:26Pharmaceutical Poisoning: Potential Scenarios
116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
2.1K
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
2.1K
01:29Hemorrhagic Stroke ll: Pathophysiology
30
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
30
01:29Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53